Diphtheria immunity in UK blood donors.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 7715300)

Published in Lancet on April 15, 1995

Authors

P A Maple1, A Efstratiou, R C George, N J Andrews, D Sesardic

Author Affiliations

1: Respiratory and Systemic Infection Laboratory, Central Public Health Laboratory, London, UK.

Articles citing this

Development of a direct PCR assay for detection of the diphtheria toxin gene. J Clin Microbiol (1997) 1.35

Persistence of a distinct Corynebacterium diphtheriae clonal group within two communities in the United States and Canada where diphtheria is endemic. J Clin Microbiol (2001) 1.07

Diphtheria antitoxin levels in the Netherlands: a population-based study. Emerg Infect Dis (1999) 0.99

Diphtheria: epidemiological update and review of prevention and control strategies. Eur J Epidemiol (1997) 0.97

Use of amplified fragment length polymorphisms for typing Corynebacterium diphtheriae. J Clin Microbiol (2000) 0.89

Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine. Infect Immun (2008) 0.82

A multicentre serosurvey on diphtheria immunity in a French population of 1004 subjects. Eur J Epidemiol (1998) 0.79

The new threats of Gram positive pathogens: re-emergence of things past. J Clin Pathol (1996) 0.75

Determination of the presence of diphtheria toxin in the myocardial tissue of rabbits and a female subject by using an immunofluorescent antibody method. J Clin Med Res (2015) 0.75

Immunity to diphtheria in a sample of the Canadian adult population. Can J Infect Dis (1998) 0.75

Immunity to diphtheria in Izmir, Turkey. Eur J Epidemiol (2000) 0.75

Serological survey on the immunity to diphtheria of the northern Greek population. Eur J Epidemiol (1997) 0.75

No influence of atopic diseases on antibody titres following tetanus, diphtheria and hepatitis B immunisation among adults. Eur J Clin Microbiol Infect Dis (2007) 0.75

Articles by these authors

Vancomycin-resistant enterococci. Lancet (1988) 11.27

Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1989) 5.65

BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax (2009) 5.23

Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet (1997) 5.22

Genetic relationships between clinical isolates of Streptococcus pneumoniae, Streptococcus oralis, and Streptococcus mitis: characterization of "Atypical" pneumococci and organisms allied to S. mitis harboring S. pneumoniae virulence factor-encoding genes. Infect Immun (2000) 4.26

High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect (1989) 3.95

Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev (1990) 3.82

emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis (1999) 3.12

Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ (2000) 3.10

Prevalence of antibiotic resistance and serotypes in pneumococci in England and Wales: results of observational surveys in 1990 and 1995. BMJ (1996) 2.92

Penicillin-resistant viridans streptococci have obtained altered penicillin-binding protein genes from penicillin-resistant strains of Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1990) 2.82

The complete genome sequence and analysis of Corynebacterium diphtheriae NCTC13129. Nucleic Acids Res (2003) 2.82

The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol (1993) 2.71

Polymerase chain reaction for screening clinical isolates of corynebacteria for the production of diphtheria toxin. J Clin Pathol (1994) 2.59

Vancomycin-resistant leuconostocs, lactobacilli and now pediococci. J Hosp Infect (1987) 2.37

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess (2010) 2.33

Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed-field gel electrophoresis, and antimicrobial resistance patterns. J Clin Microbiol (1996) 2.32

A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect (2005) 2.32

Enterococcus faecium with high-level resistance to gentamicin. Lancet (1991) 2.28

Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect (1999) 2.24

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine (2002) 2.12

Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol (1995) 2.00

Presentation and outcome of strangulated external hernia in a district general hospital. Br J Surg (1981) 1.96

Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. J Clin Microbiol (1993) 1.95

Risk factors for recurrent tuberculosis in England and Wales, 1998-2005. Thorax (2010) 1.89

Diphtheria toxin production by Corynebacterium ulcerans from cats. Vet Rec (2002) 1.82

Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health (1998) 1.80

Group A streptococcal infections during the seasonal influenza outbreak 2010/11 in South East England. Euro Surveill (2011) 1.75

A modified Elek test for detection of toxigenic corynebacteria in the diagnostic laboratory. J Clin Microbiol (1997) 1.74

Diphtheria in the United Kingdom, 1986-2008: the increasing role of Corynebacterium ulcerans. Epidemiol Infect (2010) 1.72

Fluorescent amplified-fragment length polymorphism analysis of an outbreak of group A streptococcal invasive disease. J Clin Microbiol (1998) 1.66

Antimicrobial resistance amongst enterococci isolated in the United Kingdom: a reference laboratory perspective. J Antimicrob Chemother (1993) 1.65

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun (2001) 1.64

Access to diphtheria antitoxin for therapy and diagnostics. Euro Surveill (2014) 1.61

The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60

Letter: Agglutination grouping of Streptococci. Lancet (1976) 1.56

Routine screening for Corynebacterium diphtheriae. Lancet (1990) 1.51

Estimating influenza vaccine effectiveness using routinely collected laboratory data. J Epidemiol Community Health (2009) 1.48

A quantitative descriptive study of the prevalence of carriage (colonisation) of haemolytic streptococci groups A, B, C and G in pregnancy. J Obstet Gynaecol (2011) 1.45

Laboratory guidelines for the diagnosis of infections caused by Corynebacterium diphtheriae and C. ulcerans. World Health Organization. Commun Dis Public Health (1999) 1.45

Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl (2000) 1.44

Detection of glycopeptide resistance in clinical isolates of gram-positive bacteria. J Antimicrob Chemother (1991) 1.43

A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin. Epidemiol Infect (1989) 1.42

Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis (2000) 1.42

Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. J Clin Microbiol (1995) 1.41

The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill (2005) 1.39

Invasive group A streptococcal disease: should close contacts routinely receive antibiotic prophylaxis? Lancet Infect Dis (2005) 1.37

Transferable cephalosporin resistance not inhibited by clavulanate in Escherichia coli. Lancet (1990) 1.37

Evaluation of serotype prediction by cpsA-cpsB gene polymorphism in Streptococcus pneumoniae. J Clin Microbiol (2000) 1.36

Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance. J Infect Dis (1998) 1.36

Corynebacterium imitans sp. nov. isolated from patients with suspected diphtheria. J Clin Microbiol (1997) 1.34

The serotyping of hospital strains of streptococci belonging to Lancefield group C and group G. J Hyg (Lond) (1983) 1.31

Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect (1992) 1.30

Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis (1998) 1.30

Comparison of phenotypic and genotypic methods for detection of diphtheria toxin among isolates of pathogenic corynebacteria. J Clin Microbiol (1998) 1.30

Comparison of high-level gentamicin-resistant Enterococcus faecium isolates from different continents. Antimicrob Agents Chemother (1993) 1.28

Screening tests for pathogenic corynebacteria. J Clin Pathol (1992) 1.26

High-resolution genotyping elucidates the epidemiology of group A streptococcus outbreaks. J Infect Dis (1996) 1.26

Genetics of oxacillin resistance in clinical isolates of Streptococcus pneumoniae that are oxacillin resistant and penicillin susceptible. Antimicrob Agents Chemother (1994) 1.25

Non-toxigenic Corynebacterium diphtheriae var gravis in England. Lancet (1993) 1.24

Immunological detection of Clostridium botulinum toxin type A in therapeutic preparations. J Immunol Methods (1995) 1.22

Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis (2012) 1.22

Outbreak of infection in two UK hospitals caused by a strain of Klebsiella pneumoniae resistant to cefotaxime and ceftazidime. J Hosp Infect (1992) 1.20

Molecular epidemiology of diphtheria. J Infect Dis (2000) 1.19

Pneumococci causing invasive disease in Britain 1982-1990. J Med Microbiol (1998) 1.19

Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school. BMJ (2008) 1.18

A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine (2009) 1.17

Emergence of an invasive clone of nontoxigenic Corynebacterium diphtheriae in the urban poor population of Vancouver, Canada. J Clin Microbiol (2006) 1.17

Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro. Microbiology (1997) 1.17

The ortho-nitrophenol (ONPG) test and acid from lactose in Gram-negative genera. J Clin Pathol (1973) 1.16

Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidemiol Infect (1987) 1.16

Antibody to Haemophilus influenzae type b after routine and catch-up vaccination. Lancet (2003) 1.16

PCR-enzyme-linked immunosorbent assay and sequencing as an alternative to serology for M-antigen typing of Streptococcus pyogenes. J Clin Microbiol (1997) 1.15

Increase in scarlet fever notifications in the United Kingdom, 2013/2014. Euro Surveill (2014) 1.14

Mycolic acid patterns of four vaccine strains of Mycobacterium bovis BCG. J Gen Microbiol (1983) 1.14

The contribution of respiratory pathogens to the seasonality of NHS Direct calls. J Infect (2007) 1.13

A national survey of genitourinary medicine clinic attenders provides little evidence of sexual transmission of hepatitis C virus infection. Sex Transm Infect (2003) 1.13

Mathematical modeling of antimicrobial susceptibility data of Staphylococcus haemolyticus for 11 antimicrobial agents, including three experimental glycopeptides and an experimental lipoglycopeptide. Antimicrob Agents Chemother (1990) 1.13

Nontoxigenic corynebacterium diphtheriae: an emerging pathogen in England and Wales? Emerg Infect Dis (2001) 1.12

The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiol Infect (2007) 1.12

Peritonitis due to vancomycin-resistant Staphylococcus epidermidis. Lancet (1991) 1.11

Possible zoonotic transmission of toxigenic Corynebacterium ulcerans from companion animals in a human case of fatal diphtheria. Vet Rec (2009) 1.11

Increase in invasive Streptococcus pyogenes and Streptococcus pneumoniae infections in England, December 2010 to January 2011. Euro Surveill (2011) 1.11

In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD. J Antimicrob Chemother (1993) 1.09

High-level resistance to gentamicin in Enterococcus faecium. J Antimicrob Chemother (1992) 1.08

Development of improved SNAP25 endopeptidase immuno-assays for botulinum type A and E toxins. J Immunol Methods (2007) 1.07

The emergence of vancomycin resistance in renal dialysis. J Hosp Infect (1993) 1.07

Pneumococcal bacteraemia and meningitis in England and Wales 1982 to 1992. Commun Dis Rep CDR Rev (1995) 1.06

Testing for neutralising potential of serum antibodies to tetanus and diphtheria toxin. Lancet (1992) 1.05